Revenue | ₹6.30Cr |
Net Profits | ₹0.39Cr |
Net Profit Margins | -6.19% |
Parmax Pharma Ltd’s revenue jumped 370.15% since last year same period to ₹6.30Cr in the Q3 2024-2025. On a quarterly growth basis, Parmax Pharma Ltd has generated -32.91% fall in its revenue since last 3-months.
Parmax Pharma Ltd’s net profit jumped 77.71% since last year same period to ₹0.39Cr in the Q3 2024-2025. On a quarterly growth basis, Parmax Pharma Ltd has generated -77.27% fall in its net profits since last 3-months.
Parmax Pharma Ltd’s net profit margin jumped 95.26% since last year same period to -6.19% in the Q3 2024-2025. On a quarterly growth basis, Parmax Pharma Ltd has generated -164.22% fall in its net profit margins since last 3-months.
The revenue for Parmax Pharma Ltd in the Q3 results 2024 was ₹6.30Cr.
The net profit for Parmax Pharma Ltd in the Q3 results 2024 was ₹0.39Cr.
The net profit margin for Parmax Pharma Ltd in the Q3 results 2024 was -6.19%.
The revenue for Parmax Pharma Ltd in the Q3 results 2023 was ₹1.34Cr.
The net profit for Parmax Pharma Ltd in the Q3 results 2023 was ₹-1.75Cr.
The net profit margin for Parmax Pharma Ltd in the Q3 results 2023 was -130.60%.